Mutant PPM1D and TP53 populate the hematopoietic compartment after peptide receptor radionuclide therapy (PRRT) exposure.Abhay Singh,Nuria Mencia-Trinchant,Elizabeth A. Griffiths,Medhavi Gupta,Matthew Gravina,Rutaba Tajammal,Mark G. Faber,LunBiao Yan,Eti Sinha,Duane C. Hassane,Monica L. Guzman,Renuka V. Iyer,Eunice S. Wang,Swapna ThotaJOURNAL OF CLINICAL ONCOLOGY(2021)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要